Table 1.
Characteristics | SARS-CoV | MERS-CoV | SARS-CoV-2 |
---|---|---|---|
Epidemiology | |||
Outbreaks (year) | 2002–2004 | 2012, 2015, 2018 | 2019–2020 |
Confirmed cases | 8,422 | 2494 | 6,799,713* |
Death | 916 | 858 | 397,388* |
Mortality rates % | 11 | 34.4 | 5.8* |
Age (years) | 44 | 56 | 51–56 |
Sex ratio (male to female) | 0.8:1 | 3.3:1 | 1.7:1 |
Underlying diseases % | |||
Diabetes | 24 | 36–66 | 11–19 |
Hypertension | 19 | 31–65 | 19–30 |
Cardiovascular disease | 10 | 20–41 | 4–8 |
Malignancy | 3 | 2 | 0.5–1 |
Symptoms % | |||
Fever | 99–100 | 40–100 | 94 |
Cough | 62–100 | 29–100 | 79–81 |
Dyspnea | 40–42 | 48–100 | 40 |
Myalgia | 45–61 | 32 | 15–32 |
Headache | 20–56 | 13 | 10–14 |
Sore throat | 9–25 | 7–83 | 5–8 |
Nausea or vomiting | 20–35 | 21 | 4 |
Diarrhea | 20–32 | 26 | 5 |
Laboratory findings % | |||
Lymphopenia | 65–89 | 34 | 40–65 |
Increased CRP | 78 | 63 | 52–86 |
Thrombocytopenia | 33–46 | 36 | 23–42 |
LDH elevation | 56–87 | 49 | 67–98 |
CRP, C-reactive protein; LDH, lactate dehydrogenase; MERS-CoV, Middle East respiratory syndrome coronavirus; SARS-CoV, severe acute respiratory syndrome coronavirus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Situation on June 07, 2020